Company news

Sonoma Pharmaceuticals, Inc. news in 2023

Sonoma Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

November 12, 2023

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

November 2, 2023

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

October 25, 2023

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

August 14, 2023

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

August 9, 2023

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

August 2, 2023

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

June 21, 2023

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

June 7, 2023

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

April 10, 2023

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

March 27, 2023

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

March 1, 2023

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

February 13, 2023

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

January 30, 2023

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

January 24, 2023

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

January 3, 2023

Decks in 2023